Effect of Lacidipine on Cytotoxic, Inflammatory, and Oxidative Parameters in SW480 Colon Cancer Cell Line

Year 2025, Volume: 3 Issue: 2, 70 - 74, 31.08.2025

Özge Balpınar , Muhammed Sait Ertuğrul

https://doi.org/10.62425/rtpharma.1755193

Abstract

Objective: This study aimed to evaluate the antiproliferative effects of lacidipine, a dihydropyridine-derived L-type calcium channel blocker, on the human colon cancer cell line (SW480) and the associated changes in inflammatory and oxidative stress markers.
Materials and Methods: SW480 cells were exposed to lacidipine doses ranging from 100 to 250 µg/mL. Cytotoxicity was assessed using the MTT assay. Oxidative stress levels were measured using TAC and TOS parameters, while the inflammatory response was assessed using ELISA for IL-1β, TNF-α, and TGF-β levels.
Results: Lacidipine exhibited significant cytotoxic effects at a dose of 100 µg/mL, but increased cell viability was observed at higher doses. No statistically significant changes were observed in TAC and TOS levels. However, a significant decrease in IL-1β, TNF-α, and TGF-β levels was detected due to lacidipine; the most effective dose was determined to be 150 µg/mL.
Conclusion: Lacidipine may have an antiproliferative effect by reducing inflammatory cytokine levels in SW480 colon cancer cells. These findings support the potential anticancer effect of lacidipine related to its anti-inflammatory properties, and further preclinical studies are needed to elucidate its mechanisms.

Keywords

Lacidipine , colon cancer , oxidative stress , Cytokines

References

• Balpınar, Ö., Nadaroğlu, H., & Hacımüftüoğlu, A. (2023). Green synthesis, characterization of melatonin-like drug bioconjugated CoS quantum dots and its antiproliferative effect on different cancer cells. Molecular Biology Reports, 50(11), 9143-9151. https://doi.org/10.1007/s11033-023-08817-3
• Chatki, P. K., & Tabassum, S. (2021). Analytical methods of dihydropyridines based calcium channel blockers-amlodipine, lacidipine, isradipine, nifedipine, felodipine, cilnidipine and its related formulations: a review.
• Colak, S., & ten Dijke, P. (2017). Targeting TGF-β Signaling in Cancer. Trends in Cancer, 3(1), 56-71. https://doi.org/10.1016/j.trecan.2016.11.008
• Cominacini, L., Fratta Pasini, A., Garbin, U., Pastorino, A. M., Davoli, A., Nava, C., Campagnola, M., Rossato, P., & Lo Cascio, V. (2003). Antioxidant activity of different dihydropyridines. Biochem Biophys Res Commun, 302(4), 679-684. https://doi.org/10.1016/s0006-291x(03)00158-x
• Ertugrul, M. S., Nadaroglu, H., Nalci, O. B., Hacimuftuoglu, A., & Alayli, A. (2020). Preparation of CoS nanoparticles-cisplatin bio-conjugates and investigation of their effects on SH-SY5Y neuroblastoma cell line. Cytotechnology, 72(6), 885-896. https://doi.org/10.1007/s10616-020-00432-5
• Escames, G., Khaldy, H., León, J., González, L., & Acuña-Castroviejo, D. (2004). Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine. Journal of hypertension, 22(3), 629-635. Kataoka, C., Egashira, K., Ishibashi, M., Inoue, S., Ni, W., Hiasa, K.-i., Kitamoto, S., Usui, M., & Takeshita, A. (2004). Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. American Journal of Physiology-Heart and Circulatory Physiology, 286(2), H768-H774. https://doi.org/10.1152/ajpheart.00937.2002 Klampfer, L. (2011). Cytokines, inflammation and colon cancer. Current cancer drug targets, 11(4), 451-464.
• Lee, H., Kim, J. W., Kim, D. K., Choi, D. K., Lee, S., Yu, J. H., Kwon, O. B., Lee, J., Lee, D. S., Kim, J. H., & Min, S. H. (2020). Calcium Channels as Novel Therapeutic Targets for Ovarian Cancer Stem Cells. Int J Mol Sci, 21(7). https://doi.org/10.3390/ijms21072327 Martin, T. P., McCluskey, C., Cunningham, M. R., Beattie, J., Paul, A., & Currie, S. (2018). CaMKIIδ interacts directly with IKKβ and modulates NF-κB signalling in adult cardiac fibroblasts. Cellular signalling, 51, 166-175.
• McCormack, P. L., & Wagstaff, A. J. (2003). Lacidipine: a review of its use in the management of hypertension. Drugs, 63(21), 2327-2356. https://doi.org/10.2165/00003495-200363210-00008 Papi, S., Ahmadizar, F., & Hasanvand, A. (2019). The role of nitric oxide in inflammation and oxidative stress. Immunopathologia Persa, 5(1), e08-e08.
• Park, J.-K., Fiebeler, A., Muller, D. N., Mervaala, E. M., Dechend, R., Abou-Rebyeh, F., Luft, F. C., & Haller, H. (2002). Lacidipine inhibits adhesion molecule and oxidase expression independent of blood pressure reduction in angiotensin-induced vascular injury. Hypertension, 39(2), 685-689. Sezen, S., Ertuğrul, M. S., Balpınar, Ö., Bayram, C., Özkaraca, M., Okkay, I. F., Hacımüftüoğlu, A., & Güllüce, M. (2023). Assessment of antimicrobial activity and In Vitro wound healing potential of ZnO nanoparticles synthesized with Capparis spinosa extract. Environmental Science and Pollution Research, 30(55), 117609-117623. https://doi.org/10.1007/s11356-023-30417-8
• Sheng, Y., Qiao, C., Zhang, Z., Shi, X., Yang, L., Xi, R., Yu, J., Liu, W., Zhang, G., & Wang, F. (2025). Calcium Channel Blocker Lacidipine Promotes Antitumor Immunity by Reprogramming Tryptophan Metabolism. Advanced Science, 12(3), 2409310.
• Suleyman, H., Halici, Z., Hacimuftuoglu, A., & Gocer, F. (2006). Role of adrenal gland hormones in antiinflammatory effect of calcium channel blockers. Pharmacological reports, 58(5), 692.
• Taghizadehghalehjoughi, A., Sezen, S., Bayram, C., Hacımüftüoğlu, A., & Güllüce, M. (2020). Investigation of anti-tumor effect in neuroblastoma cell line; amlodipine & metformin. Anatolian Journal of Biology, 1(1), 16-21.
• Taghizadehghalehjoughi, A., Sezen, S., Hacimuftuoglu, A., & Güllüce, M. (2019). Vincristine combination with Ca+ 2 channel blocker increase antitumor effects. Molecular Biology Reports, 46(2), 2523-2528.
• van Amsterdam, F. T., Roveri, A., Maiorino, M., Ratti, E., & Ursini, F. (1992). Lacidipine: a dihydropyridine calcium antagonist with antioxidant activity. Free Radic Biol Med, 12(3), 183-187. https://doi.org/10.1016/0891-5849(92)90025-c
• Wang, L., Tassiulas, I., Park-Min, K.-H., Reid, A. C., Gil-Henn, H., Schlessinger, J., Baron, R., Zhang, J. J., & Ivashkiv, L. B. (2008). 'Tuning'of type I interferon–induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nature immunology, 9(2), 186-193.
• Wang, Q. L., Zhao, L., Feng, N., Zhou, P., Wu, Q., Fan, R., Li, J., Zhang, S. M., Wang, Y. M., Xu, X. Z., Yu, S. Q., Yi, D. H., & Pei, J. M. (2015). Lacidipine attenuates TNF-α-induced cardiomyocyte apoptosis. Cytokine, 71(1), 60-65. https://doi.org/10.1016/j.cyto.2014.08.004
• Wong, B. S., Chiu, L. Y., Tu, D. G., Sheu, G. T., & Chan, T. T. (2020). Anticancer Effects of Antihypertensive L-Type Calcium Channel Blockers on Chemoresistant Lung Cancer Cells via Autophagy and Apoptosis. Cancer Manag Res, 12, 1913-1927. https://doi.org/10.2147/cmar.S228718
• Xue, C., Yao, Q., Gu, X., Shi, Q., Yuan, X., Chu, Q., Bao, Z., Lu, J., & Li, L. (2023). Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduction and Targeted Therapy, 8(1), 204. https://doi.org/10.1038/s41392-023-01468-7